Blepharoptosis is a common complaint of eyelid malposition in which the upper eyelid is lower than normal. There are multiple types of blepharoptosis based on cause, and important studies have recently been published on one type, myogenic blepharoptosis. There have classically been three methods for correcting blepharoptosis. For the most severe cases, frontalis slings are often performed. New materials, such as polyester mesh, have shown promise as alternatives in forming frontalis slings. A recent paper has suggested a new algorithm for another method of blepharoptosis correction, the conjunctiva-Müller muscle resection. The effectiveness of the third type of procedure for blepharoptosis correction, the external levator advancement, has been reinforced in a study examining the procedure in cases of congenital blepharoptosis. Blepharoptosis, or drooping of the upper eyelid, is a common ophthalmic problem found in all age groups. It has multiple causes. Many, but not all, types of blepharoptosis are treated surgically. There are three classic surgical procedures for the treatment of ptosis: frontalis suspension, levator resection, and Müller muscleconjunctival resection. There are variations on the execution and materials used for each of these procedures, but basic principles hold true within each category. Which type of surgical procedure, if any, is appropriate for a given patient's ptosis is determined by the cause and extent of the ptosis.
Etiologic classification
The successful correction of upper eyelid ptosis begins with the accurate identification of the cause of the ptosis. The ptosis can then be treated with the appropriate surgery or medical therapy. Ptosis can be divided into one of six subtypes: levator maldevelopment (including congenital ptosis), myogenic, neurogenic, aponeurotic, mechanical, and pseudoptosis. To classify a ptosis into one of these categories, a thorough medical history and physical examination must be performed and certain tests may be necessary.
The history includes the time of onset of the ptosis, associated symptoms, progression or fluctuating course of the ptosis, and any previous treatment. A complete ophthalmologic examination should be performed. It should include visual acuity, pupillary examination, motility examination, evaluation of Bell and jaw-winking phenomena, slit-lamp examination to note any keratopathy, funduscopic examination, and lacrimal function tests including Schirmer 1 and basic tear secretion tests. Eyelid measurements should include palpebral fissure height, levator muscle function, margin limbus distance in cases of congenital ptosis, margin to eyelid crease and fold distances, and the function of Müller muscle with phenylephrine stimulation. The most important eyelid measurement is margin reflex distance one (MRD 1 ), the distance from the light reflex on the patient's cornea to the central upper eyelid margin in primary gaze position. More thorough testing should be pursued as the case dictates.
Whereas most studies have investigated ptosis based on the type of surgical correction attempted, one of the most important studies reported since February 2001 explored ptosis based on its cause. Wong et al. [1••] looked at the management of myogenic ptosis. These authors, in a ret-rospective, noncomparative case series, reviewed 28 consecutive cases of myogenic ptosis during an 8-year period. Chronic progressive external ophthalmoplegia was the most common cause (43%), followed by oculopharyngeal muscular dystrophy and myotonic dystrophy (18% each), and Kearns-Sayre syndrome (14%). Mitochondrial myopathy/encephalopathy/lactic acidosis/and stroke-like episodes and oculopharyngodistal myopathy each accounted for 4% of patients. Twenty-five of 28 patients needed surgical management of their ptosis. Surgery was indicated when there was substantial impairment of vision due to obstruction of the visual axis. Fourteen (50%) of the patients underwent frontalis suspension surgery. This procedure was used in patients with levator function less than 8 mm. Eleven (39%) had levator advancement and resection. In addition to treatment of the ptosis, these patients required follow-up and treatment for such things as dysphagia (43%), pigmentary retinopathy (25%), diplopia (18%), cataract (14%), heart block (14%), and deafness (11%). Burnstine and Putterman [2] used an alternative procedure. They showed that blepharoplasty can be used to create a functional sling with which to elevate the eyelids. Twelve eyelids of six patients underwent an upper blepharoplasty to create a physiologic sling between the upper eyelid and eyebrow via excision of skin and orbicularis muscle. All patients had an increase in MRD 1, which averaged an elevation of 3.25 mm. There was no increase in ocular discomfort, lagophthalmos, or exposure keratopathy postoperatively. (The procedure has been performed in an additional four patients with similar good results.)
A much smaller and less quantitative report by Kang et al. [3] , reported that correction of blepharoptosis secondary to oculopharyngeal muscular dystrophy could be safely achieved with levator resections. The authors attributed this to the fact that orbicularis function and Bell phenomenon remain intact and help guard against keratopathy. The number of patients in this study was only four, and scarce to no follow-up or endpoint data were given.
Another study that investigated blepharoptosis from an etiologic standpoint was reported by Bradley et al. [4] , who described treatment of blepharoptosis in patients with myasthenia gravis (MG). Ten patients, eight with ocular MG and two with systemic MG, underwent a total of 16 blepharoptosis procedures (nine external levator advancements, six frontalis slings, and one tarsomyectomy) for correction of MG refractory to medical treatment. Complications noted afterward included worsening diplopia and exposure keratopathy in one patient each. One interesting finding of this study is that given even severe ptosis, most patients had enough eyelid excursion to justify an external levator advancement instead of frontalis slings. The study did have its shortcomings. It used interpalpebral fissure height, which can be influenced by the position of the lower eyelid, instead of the margin reflex distance, which is more specific to the upper lid. It also was a retrospective study and lacked any control cases.
Frontalis suspension (sling) Indications and technique
The basic principle of the frontalis suspension is to use the frontalis muscle to elevate the eyelids. Many surgical techniques and sling configurations have been described. [5, 6] This procedure is most often used in cases of congenital ptosis in which there is less than 4 mm of levator function. It may also be used in other cases of poor levator function, including external ophthalmoplegia, third-nerve paralysis, and MG. However, as in the study by Wong et al. reviewed earlier, this is not an absolute rule, and the procedure may be used in cases in which there is currently more the 4 mm of levator function but in which a decrease in function is anticipated.
Materials
Various materials have been used in the past to form the sling. The material of choice for many years has been autogenous fascia lata. However, autogenous fascia lata has its drawbacks, including the need for a second operative site, scarring on the leg, and a required height of the patient of at least 97 cm (38 inches). Other materials have included banked fascia lata and synthetic material such as polyester suture, silicone, nylon suture, polypropylene, and expanded polytetrafluoroethylene (ePTFE). Several studies investigated the value of various forms of brow suspensory material. Wasserman et al. [7] performed a retrospective analysis of 102 frontalis suspension procedures performed in 43 patients. They compared recurrent ptosis rates and rates of infection or granuloma formation in patients in whom autogenous fascia lata, banked fascia lata, monofilament nylon, braided polyester, ePTFE, or polypropylene was used. All patients had at least 6 months of follow-up unless infection/granuloma formation or recurrent ptosis occurred before this time. Their study showed that infection or granuloma formation occurred in 45.5% of eyelids (5 of 11) in which ePTFE was used. In all other materials, the rate of infection or granuloma formation was less than 10%. The rate of recurrent ptosis was lowest in autogenous fascia lata at 4.2% (1 of 24 eyelids) and ePTFE with 0% (0 of 11 eyelids). The rate of recurrence was highest in banked fascia lata at 51.4% (18 of 35 eyelids). The authors concluded that autogenous fascia lata was the material of choice when it can be harvested. They also speculated that the higher recurrent ptosis rate seen with synthetic materials may have been at least in part because they were used in younger patients unable to undergo harvesting of autogenous fascia lata. They postulated that the faster growth rate or the young age of their patients increased the risk of recurrent ptosis.
Two studies investigated polyester mesh (Mersilene) (Ethicon Corp., Sommerville, NJ) as a sling material. ElToukhy et al. [8•] compared polyester mesh to autogenous fascia lata. In their study, patients with various causes of ptosis were prospectively divided into two groups and treated with frontalis slings. Forty-two eyes of 36 patients were treated with polyester mesh, and 34 eyes of 24 patients were treated with autogenous fascia lata. Sling construction was similar between the two groups. Levator function and preoperative and postoperative MRD 1 measurements were similar in both groups. Follow-up was at least 24 months, with an average of 33.8 months in both groups. Residual ptosis was less often experienced in the polyester mesh group than in the autologous fascia lata group (5% vs 18%). Asymmetry and lagophthalmos were similar in comparing the two groups. Repeat surgery and corneal exposure both occurred once in the polyester mesh group and twice in the autologous fascia lata group. No exposure of the sling occurred in any patient. The authors concluded that polyester mesh surpasses all synthetic and homogenous materials currently available and that its availability, inexpensiveness, and durability make it a good alternative to autogenous fascia lata.
In a smaller study, Kemp and MacAndie [9] performed a retrospective review of 29 eyes in 20 patients who had polyester mesh used as a sling material. Follow-up ranged from 7 to 43 months. The authors reported good results and identified previous ptosis surgery and Marcus Gunn jaw-winking syndrome as risk factors for a poor outcome with minimal elevation of the eyelid. They had one sling exposure at 3 years but no infections or overcorrection with resultant corneal exposure. Although both that study and the one by El-Toukhy et al. [8•] demonstrated that polyester mesh has promise as a sling material, a greater number of cases and longer follow-up periods are needed to verify the usefulness of polyester mesh.
Tellioglu et al. [10] reported the use of a deep temporal fascial graft as sling material. Although this graft site has been used by Neuhaus and Shorr [11] , for the ophthalmologist, the deep temporal fascia is an infrequently used site of autogenous tissue [11] . Its advantages are that it is autogenous, can be harvested in the same surgical field as the ptosis correction procedure, and can be obtained with the patient under local anesthesia. The incision at the harvest site can be hidden behind the hairline, and harvesting can be done under direct vision. However, the surgeon must be knowledgeable about the neural, vascular, and muscular anatomy in the area of the temporal fascia to avoid such complications as brow ptosis.
Levator resection Indications
A levator resection is indicated for correction of congenital or myogenic ptosis with levator function of 4 mm or greater. It is also indicated for any aponeurotic ptosis that does not elevate with phenylephrine stimulation [6] .
Technique
As with the frontalis suspension procedure, there are several techniques for this type of ptosis surgery. The basic principle is the isolation and advancement of the levator aponeurosis and muscle. The levator can be approached from either an anterior or posterior eyelid incision. The techniques are described in detail in references 5 and 6.
Results
Cates and Tyers [12•] studied the results of correction of congenital ptosis by anterior levator resection. They followed 100 patients who had surgery on a total of 108 eyelids. All had congenital ptosis without associated ocular motility disturbance, blepharophimosis, or Marcus Gunn phenomenon, and all had levator function of 4 mm or greater. Resections were performed using the guidelines of Beard [13] and Berke [14] . Success was defined as eyelid levels within 1 mm of each other postoperatively. Of those undergoing primary procedures, 75% of the unilateral cases were considered successful at 6 months and 64% of bilateral cases were successful at 6 months. Of cases that were reoperations (all were unilateral), 67% were successful at 6 months. The Cates and Tyers found that in the primary procedure group, the rate of undercorrection at 6 months was 18% and overcorrection was 7%; the most important factor in determining success was levator function. Less levator function more often resulted in undercorrection. These findings are consistent with those of previous studies [15] and guide the surgeon to perform larger resections in patients with poorer levator function.
Mü ller muscle-conjunctival resection (Putterman procedure) Indications
The Müller muscle-conjunctival resection procedure was described by Putterman and Urist [15] in 1975 and is one we use frequently. It is first-line treatment for ptosis of any etiology in which elevation of the ptotic eyelid occurs with instillation of topical phenylephrine. The patient is evaluated by measuring the MRD 1 bilaterally. Topical phenylephrine 2.5% or 10% solution is then placed in the superior cul-de-sac while the patient is in a reclined position [16] . The patient receives three drops of phenylephrine over the course of 1 minute, and a final drop is applied 1 minute later. After several minutes, the patient is placed in a sitting position and the MRD 1 is remeasured. The eyelid height attained with the instillation of topical phenylephrine can be achieved with an 8.25 mm Müller muscle-conjunctival resection. Adjustments can be made to this by resecting 1 mm more or less for every 0.5 mm of greater or lesser elevation desired, respectively. Resection can be from 6.5 to 9.5 mm above the superior tarsal border.
Technique
The Putterman procedure is performed with the patient under local anesthesia. One and one half milliliters of 2% lidocaine with 1:100,000 U of epinephrine solution is used in a frontal nerve block. One fourth of a milliliter of the same solution is injected at the central upper eyelid near the lid margin, and a 4-0 silk traction suture is placed through the skin, orbicularis muscle, and partialthickness tarsus 2 mm from the lid margin. The eyelid is everted over a Desmarres retractor, and 0.5% topical tetracaine solution is applied to the conjunctiva. A caliper is used to measure the predetermined amount of resection, and this amount is marked nasally, centrally, and temporally with a 6-0 silk marking suture. Toothed forceps are then used to pull conjunctiva and Müller muscle from the levator. A Putterman ptosis clamp (Karl Ilg & Co., St. Charles, IL) is then applied (Fig. 1) . One blade is place with the teeth at the level of the 6-0 silk marking suture, and the other blade is attached just superior to the superior tarsal border. Skin and the clamp are pulled in opposite directions to ensure that levator is not entrapped in the clamp. If it is, the clamp must be removed and reapplied. A 5-0 plain gut suture is passed in a mattress fashion temporally to nasally with 1.5 mm between the suture and the edge of the clamp. A number 15 Bard-Parker scalpel blade angled toward and sliding against the clamp is used to excise the conjunctiva and Müller muscle (Fig. 2) . The 5-0 plain gut suture is then run nasally to temporally, attaching conjunctiva to conjunctiva. The suture is tied to itself temporally and buried subconjunctivally. Results of the procedure are demonstrated in Figure 3 .
Julian et al. [17] have introduced a new algorithm for the Müller muscle-conjunctival resection. They propose that 9 mm of excision of Müller's muscle should result in roughly the same elevation that is produced by maximal stimulation after phenylephrine instillation. They also propose that any additional elevation can be achieved by excision of tarsus in a 1:1 ratio in millimeters of further desired elevation to tarsus excision. Using this algorithm, they reported postoperative symmetry, defined as eyelid levels within 0.5 mm, in 87% of patients. Patient satisfaction, based on symmetry, contour, height, and lack of desire for revision after one repair, was reported to be 95%. Although this algorithm addresses cases in which elevation to the level of maximum Müller muscle is desired, we have found that in some patients, less elevation is needed because of concerns of potential keratopathy or need for symmetry. We therefore use the algorithm outlined earlier in this section to give guidance for these types of cases. An additional study on Müller muscle-conjunctival resection by Dailey et al. [18] explored the effect of this procedure on tear production. The authors used the Schirmer basic tear secretion test to determine dry eye status preoperatively and postoperatively. Thirty-eight patients who underwent 71 ptosis repair procedures were included in the study. Before surgery, 34% of eyes measured dry. This ratio remained unchanged with longterm follow-up. Eighteen percent of patients converted from normal basic tear secretion status to dry eye after surgery, but an equal percentage went from dry eye to normal basic tear secretion status. Transient dry eye symptoms were reported in at least one eye of 29% of patients in the 2 weeks after surgery. These findings compare favorably to a study published in 1978 by Putterman and Urist [19] , in which the basic secretion tear test was normal preoperatively and postoperatively in all 46 patients tested. No comment was made about any transient dry eye symptoms. In the earlier study, the first 31 consecutive procedures had the Müller muscle-conjunctival specimen studied histologically. The specimens were found to contain few conjunctival goblet cells.
In conclusion, blepharoptosis is a common problem with a wide variety of etiological factors. Proper treatment is determined by the cause of the blepharoptosis and by factors such as the degree of blepharoptosis, levator function, and elevation of the ptotic eyelid with phenylephrine. With proper evaluation and diagnosis, most patients can obtain good cosmetic and functional results.
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